The big earners in a lucrative medical market
Tuesday 19 December 1995
According to John Hodgson, European publishing manager of Bio/technology magazine, some 26 genetically engineered pharmaceuticals have now been licensed for use around the world - 20 of which have been accepted in the UK.
Amgen, the American start-up biotechnology company, has the two top- selling genetically engineered drugs in the US. The company's Neupogen, which is used to stimulate the production of white blood cells following cancer treatment, had US sales of more than $719m last year.
In the rankings of revenue earners, Neupogen is closely followed by Epogen, an Amgen drug to stimulate the production of red blood cells. This generated US revenues of $587m last year. Such drugs are needed to treat cases of serious anaemia, which particularly afflicts people who have to undergo kidney dialysis. Amgen markets Epogen itself, but has an agreement with Ortho-Biotech to market a related red-blood cell stimulating product, known as Procrit, which is worth $500m a year in the US market.
Perhaps the most widely-used drug is human insulin for the treatment of diabetes which, produced by Genentech and marketed by Eli Lilly, has US revenues of around $560m a year. Insulin was one of the first "recombinant DNA" (genetically engineered) drugs to be approved for medicinal use, in 1982. Genentech also produces recombinant human growth hormone which is used to treat pituitary dwarfism and has annual US sales of $217m.
Life & Style blogs
Sustained immigration has not harmed Britons' employment, say government advisers
British jihadist calls for 'flag of Islam' over Downing Street and Buckingham Palace
Australia facing international condemnation after turning around Sri Lankans at sea
7/7 memorial defaced on anniversary of 2005 attacks with ‘Blair lied thousands died’ graffiti
Even when it brutalises one of its own teenage citizens, America is helpless against Israel
There’s a nasty smell in the political air – and it’s coming from the Tories
- 1 Howard Jacobson: Let's see the 'criticism' of Israel for what it really is
- 2 Instagram of US airport security chiefs: Lipstick knives and IED training kits among items seized
- 4 PornHub begs users to stop uploading video clips of Brazil getting beaten 7-1
£60000 - £75000 per annum: Harrington Starr: Business Analyst Consultant (Fina...
£60000 per annum: Harrington Starr: A leading provider in investment managemen...
£600 - £700 per day: Harrington Starr: AVS, JVS Openlink Endur Developer JVS, ...
£45000 - £60000 per annum + competitive: Progressive Recruitment: Exciting opp...